In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
Commentary|Podcasts|August 25, 2023
ESG Evolution
Author(s)Nicholas Saraceno, Senior Editor
In this PC Podcast episode, Susanne Katus discusses the increasing number of regulations impacting both pharma and biotech companies.
Advertisement
In this exclusive PC Podcast interview, Susanne Katus, SVP, market leader, corporate secretary at Datamaran, a platform that monitors and analyzes risk factors, dives into:
- The growing number of environmental, social, and governance (ESG) regulations impacting these aforementioned businesses
- Where the responsibility lies for them in terms of ESG compliance
- What can be done in order for these corporations to be ahead of the game
- Why ESG should be a top priority
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Advertisement
Related to this article
In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and HRSA's 340B rebate pilot deadline arrives.
Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: PhRMA Sues to Block GLOBE Model and Bayer's $2.2B Ohio Site
2
Why PhRMA Sued to Block Medicare's GLOBE Pricing Model
3
LogiPharma USA 2026: Data Readiness Must Come Before AI
4
Supply Chain Visibility Needs Context Before AI, Says PAXAFE’s Mark Talens
5